- CM Yogi urges health teams to raise awareness about medication among state residents
- 20% of population receives medication within 4 days of door-to-door campaign conducted by health team
By Our Correspondent
Lucknow: In a dedicated push to eradicate filariasis from the region, the Yogi government has initiated a door-to-door administration of anti-filarial medications across several districts as part of the Mass Drug Administration (MDA) campaign. In line with the directives of Chief Minister Yogi Adityanath, this initiative aims to reach every household in the state in the battle against the debilitating disease.
As a result of effective monitoring by Chief Minister Yogi Adityanath, within the first four days of the door-to-door campaign itself, about 20 percent of people have consumed the medicine. This campaign will run until February 28.
Furthermore, Chief Minister Yogi Adityanath has urged the healthcare teams not only to distribute the medication, but also to educate the populace, emphasizing the importance of awareness in achieving the campaign’s goals.
State triumphs many serious diseases with dedicated efforts of CM Yogi
Since assuming office in 2017, Chief Minister Yogi Adityanath has embarked on a crusade against numerous serious diseases prevalent in the state. His proactive stance has led to a significant turnaround, with Uttar Pradesh now free from many diseases that once afflicted its populace under previous administrations.
Building on this momentum, the Yogi government has set an ambitious target to eradicate filariasis from the state by 2026, aligning with the central government’s goal to achieve nationwide elimination by 2027. Globally, the target for eliminating this disease has been set for 2030.
The decisive action taken by the Yogi government underscores its steadfast commitment to eradicating filariasis. Tangible progress is evident on the ground, with door-to-door administration of anti-filarial medication ensuring broad coverage. Simultaneously, identified patients receive specialized training and support through the Morbidity Management and Disability Prevention (MMDP) program. Those with mild infections benefit from a regimen of regular medication and exercise, facilitating their continuous recovery.
If you experience headache and fever after taking medication, there’s no need to worry
In various districts across the state, alongside receiving anti-filarial medication, people are actively seeking to enhance their understanding of this disease. Communities in areas such as Amethi, Azamgarh, Ballia, and Barabanki have displayed keen interest in learning about the potential side effects of the medication. They inquire about issues such as headaches, dizziness, and the medication’s efficacy on an empty stomach.
The health teams are assuring the populace that the anti-filarial medication is entirely safe, despite occasional symptoms like headache, body pain, fever, vomiting, rashes, and itching, which typically subside on their own. They emphasize the importance of consuming the medication after a meal to maximize its effectiveness and minimize any discomfort.
In other areas like Lucknow, Unnao, Shahjahanpur, Bareilly, and Hamirpur, initial hesitancy towards taking the medication has been observed among some individuals. However, after receiving information from the health teams, many have willingly come forward to receive the treatment.
In the villages, health teams are actively engaging with residents, providing information about the medication and facilitating its administration. Additionally, members of the Filaria Patient Network are playing a crucial role in raising awareness about the importance of taking anti-filarial medication, further contributing to the success of the campaign.
20% of people took anti-filarial medicine within four days
Dr. Ramesh Singh Thakur, the State Program Officer for Filariasis, revealed that the MDA campaign aims to administer medication to a total of 3,60,25,891 individuals. Impressively, within just four days, approximately 66 lakh 14 thousand 589 people, constituting around 20 percent of the target population, have already received the anti-filarial medicine.
Filariasis, commonly known as elephantiasis, is a chronic and incurable disease that severely impacts the lymphatic system. This intricate network of vessels, organs, and specialized cells is profoundly impacted by filariasis infection, with symptoms often manifesting 10-15 years after contraction. Concealing symptoms can exacerbate the condition, making it imperative to seek timely assistance from Ayushman Arogya Mandir or government health centers to access the array of benefits extended by the Yogi government’s progressive schemes.
Currently, there are 51 districts in the state grappling with filariasis. The ongoing campaign is operational in 17 of these districts.
